neonat
sepsi
diagnosi
made
infant
less
day
life
consist
clinic
syndrom
may
includ
system
sign
infect
circulatori
shock
multisystem
organ
failur
neonat
sepsi
may
divid
two
type
earlyonset
neonat
sepsi
eon
lateonset
neonat
sepsi
lon
eon
typic
describ
infect
sepsi
occur
within
first
hour
first
week
life
lon
label
hour
first
week
life
day
month
literatur
vari
definit
eon
lon
categor
eon
within
first
hour
life
lon
time
period
day
propos
need
creat
unifi
definit
worldwid
develop
accuraci
diagnosi
treatment
eon
lon
classif
neonat
separ
even
depend
age
weight
newborn
infant
within
first
hour
life
neonat
day
old
preterm
infant
born
gestat
age
less
week
term
infant
born
week
gestat
low
birth
weight
lbw
consid
less
gram
low
birth
weight
vlbw
less
g
extrem
low
birth
weight
elbw
use
describ
neonat
less
g
design
becom
signific
discuss
etiolog
risk
factor
neonat
sepsi
neonat
sepsi
also
defin
clinic
diagnos
confirm
posit
cultur
typic
steril
bodili
fluid
gold
standard
diagnosi
neonat
sepsi
posit
cultur
blood
urin
cerebrospin
fluid
periton
fluid
steril
tissu
total
citat
limit
search
articl
publish
english
languag
includ
human
studi
yield
total
citat
articl
manual
review
relev
total
citat
remain
cite
contain
relev
inform
contain
outdat
inform
supersed
recent
articl
worldwid
neonat
sepsi
occur
live
birth
account
infant
child
death
annual
prospect
studi
perform
sever
neonat
center
south
korea
incid
rate
neonat
sepsi
per
live
birth
posit
cultur
per
live
birth
clinic
diagnos
neonat
sepsi
fatal
rate
studi
cultureconfirm
neonat
sepsi
clinic
diagnos
neonat
sepsi
analysi
perform
taiwan
found
incid
rate
live
birth
diagnos
neonat
sepsi
either
clinic
posit
cultur
retrospect
studi
netherland
show
decreas
incid
eon
incid
lon
studi
increas
review
unit
state
us
report
eon
occur
vlbw
infant
lon
vlbw
infant
epidemiolog
studi
cultur
posit
diagnos
neonat
sepsi
switzerland
nation
incid
live
birth
mortal
rate
systemat
review
investig
global
burden
neonat
sepsi
show
annual
incid
three
million
case
neonat
sepsi
worldwid
mortal
rate
organ
pathogen
associ
neonat
sepsi
differ
depend
upon
countri
involv
pathogen
rang
gram
posit
neg
bacteria
virus
fungi
bacteria
frequent
identifi
commonli
implic
bacteria
includ
staphylococcu
aureu
coagulas
neg
staphylococci
con
streptococcu
pneumonia
streptococcu
pyogen
escherichia
coli
klebsiella
pneumonia
pseudomona
aeruginosa
salmonella
typhi
group
b
streptococcu
gb
virus
includ
echoviru
enteroviru
parechoviru
coxsacki
viru
adenoviru
parainfluenza
viru
rhinoviru
herp
simplex
viru
respiratori
syncyti
viru
coronaviru
candida
albican
candida
speci
common
fungi
associ
neonat
sepsi
american
academi
pediatr
aap
began
recommend
use
intrapartum
antibiot
prophylaxi
iap
prevent
perinat
gb
aap
american
colleg
obstetrician
gynecologist
institut
guidelin
univers
screen
cultur
pregnant
women
gestat
due
widespread
use
prophylact
antibiot
neonat
particularli
intrapartum
antibiot
use
mother
posit
cultur
gb
incid
gbsassoci
neonat
sepsi
declin
significantli
decreas
us
period
countri
canada
taiwan
recommend
univers
use
iap
seen
declin
incid
neonat
sepsi
secondari
gb
infect
well
countri
iap
util
common
caus
agent
neonat
sepsi
escherichia
coli
gramposit
organ
eon
typic
associ
vertic
transmiss
pathogen
mother
child
common
pathogen
gb
escherichia
coli
con
haemophilu
influenza
listeria
monocytogen
lon
commonli
associ
iatrogen
nosocomi
infect
common
pathogen
con
follow
staphylococcu
aureu
escherichia
coli
risk
factor
includ
central
venou
cathet
use
invas
medic
devic
well
prolong
hospit
risk
factor
includ
preterm
ruptur
membran
amnion
meconium
aspir
lbw
vlbw
elbw
preterm
birth
greater
three
vagin
examin
labor
fever
mother
labor
infect
mother
labor
fullterm
infant
male
greater
incid
sepsi
compar
femal
infant
associ
found
preterm
infant
studi
perform
us
found
signific
dispar
increas
incid
mortal
secondari
neonat
sepsi
among
children
low
household
incom
background
versu
affluent
household
consid
rel
subtl
find
seen
clinic
assess
neonat
signific
risk
delay
recognit
sepsi
omin
clinic
find
vital
sign
abnorm
develop
earli
onset
type
may
histori
fetal
distress
includ
fetal
tachycardia
peripartum
period
soon
deliveri
may
clinic
clue
meconiumstain
amniot
fluid
low
apgar
score
initi
neonat
assess
caretak
may
give
histori
feed
intoler
irrit
excess
sleepi
look
right
vital
sign
derang
includ
hypothermia
fever
fever
common
term
babi
wherea
preterm
babi
often
demonstr
hypothermia
may
tachycardia
bradycardia
sign
poor
perfus
includ
cool
pale
extrem
rapid
threadi
puls
respiratori
symptom
sign
common
neonat
sepsi
includ
grunt
nasal
flare
use
accessori
muscl
respir
cyanosi
episod
apnea
neurolog
symptom
sign
includ
lethargi
seizur
irregular
respir
high
pitch
cri
hypotonia
hypoact
deep
tendon
reflex
abnorm
primit
reflex
gastrointestin
sign
includ
decreas
feed
vomit
diarrhea
jaundic
abdomin
distens
hepatosplenomegali
skin
find
includ
petechia
impetigo
cellul
abscess
underli
metabol
acidosi
secondari
poor
perfus
manifest
tachypnea
respiratori
distress
absenc
respiratori
tract
infect
symptom
sign
neonat
sepsi
often
subtl
vagu
imper
perform
diagnost
test
neonat
signific
risk
factor
concern
sign
symptom
variou
multivari
predict
score
system
base
retrospect
studi
may
use
predict
need
antibiot
extens
laboratori
evalu
neonat
versu
observ
concern
sign
symptom
one
exampl
eon
calcul
base
larg
retrospect
popul
studi
perform
us
support
clinician
decis
start
antibiot
neonat
suspect
sepsi
newborn
prior
probabl
eon
obtain
matern
risk
factor
chorioamnion
prematur
ruptur
membran
combin
find
base
clinic
examin
creat
score
system
determin
need
antibiot
level
monitor
requir
tabl
score
system
shown
reduc
proport
newborn
undergo
extens
laboratori
evalu
administr
antibiot
without
advers
effect
number
need
treat
nnt
highrisk
group
requir
antibiot
determin
score
system
still
highlight
challeng
involv
come
better
diagnost
tool
pick
eon
earli
stage
complet
blood
count
cbc
perform
assess
total
differenti
white
blood
cell
count
wbc
absolut
immatur
neutrophil
count
ratio
immatur
total
neutrophil
count
although
absolut
leukocytosi
low
sensit
neonat
sepsi
may
aid
clinic
decisionmak
case
lowtomoder
clinic
suspicion
sepsi
present
interestingli
low
wbc
count
low
absolut
neutrophil
count
anc
immatur
total
neutrophil
ratio
greater
shown
highli
predict
infect
obtain
ratio
divid
total
neutrophil
count
shown
better
specif
area
curv
anc
alon
diagnos
eon
ratio
would
account
elev
immatur
neutrophil
neutropenia
worri
background
sepsi
sensit
specif
likelihood
ratio
area
curv
anc
found
highest
hour
birth
compar
anytim
earlier
limit
includ
skill
laboratori
personnel
perform
manual
count
well
limit
specif
also
import
note
multipl
variabl
affect
variou
compon
wbc
includ
cri
neonat
gestat
age
arteri
versu
venou
sampl
blood
cultur
remain
gold
standard
confirm
sepsi
limit
low
sensit
durat
time
cultur
determin
posit
often
around
hour
fastidi
organ
matern
antibiot
small
sampl
collect
limit
sensit
blood
cultur
fals
posit
may
occur
due
inadequ
skin
antisepsi
prior
sampl
collect
least
ml
blood
collect
improv
diagnost
yield
sampl
collect
two
differ
site
reduc
fals
posit
result
central
venou
cathet
present
blood
cultur
taken
line
separ
peripher
sourc
assess
differenti
time
posit
help
distinguish
catheterassoci
infect
sourc
infect
implic
clinic
manag
swab
cultur
surfac
site
eye
ear
umbilicu
groin
throat
pharynx
rectum
may
provid
inform
colon
organ
howev
contribut
decis
start
antibiot
especi
neonat
appear
well
clinic
examin
placent
cultur
may
indic
possibl
pathogen
fetu
expos
indic
infect
placent
cultur
result
therefor
use
reason
antibiot
therapi
urinari
tract
infect
uncommon
first
hour
life
urin
cultur
therefor
perform
evalu
lon
lumbar
punctur
lp
routin
perform
neonat
show
sign
eon
lon
neonat
cultureposit
bacteremia
concomit
mening
lp
perform
neonat
whose
blood
cultur
posit
perform
promptli
neg
blood
cultur
rule
mening
individu
posit
cerebrospin
fluid
csf
gram
stain
cultur
fals
neg
csf
gram
stain
cultur
may
occur
neonat
treat
antibiot
prior
lp
acut
phase
reactant
creactiv
protein
crp
procalcitonin
interleukin
level
presepsin
haptoglobin
neutrophil
investig
potenti
biomark
neonat
sepsi
crp
may
elev
earli
stage
infect
due
time
taken
synthesi
liver
eventu
appear
blood
serial
measur
crp
combin
acut
phase
reactant
procalcitonin
may
improv
diagnost
accuraci
procalcitonin
pct
specif
crp
bacteri
infect
rise
rapidli
respons
infect
crp
normal
birth
weight
infant
pct
level
greater
ngml
associ
nosocomi
infect
wherea
level
greater
ngml
vlbw
infant
prompt
antibiot
therapi
shown
procalcitoninguid
decis
make
superior
standard
care
reduc
antibiot
therapi
neonat
suspect
eon
pct
level
howev
elev
noninfecti
condit
respiratori
distress
syndrom
pneumothorax
intracrani
hemorrhag
hemodynam
instabl
serial
pct
concentr
may
util
evalu
neonat
sepsi
although
pct
physiolog
increas
absenc
infect
first
hour
life
presepsin
found
high
level
diagnost
accuraci
recommend
valuabl
marker
neonat
sepsi
albeit
singl
diagnost
test
metaanalysi
perform
investig
potenti
conclud
could
use
valid
marker
earli
diagnosi
sepsi
neonat
care
unit
autom
blood
cultur
system
monitor
continu
posit
signal
improv
time
detect
pathogen
matrixassist
laser
desorpt
ioniz
timeofflight
malditof
mass
spectroscopi
identifi
organ
blood
cultur
much
earlier
allow
antibiot
therapi
specif
organ
involv
multiplex
polymeras
chain
reaction
pcr
detect
ident
bacteria
fungi
well
presenc
antimicrobi
resist
gene
within
hour
identif
pathogen
pcr
perform
blood
bodi
fluid
directli
without
need
first
cultur
caus
organ
quantit
realtim
amplif
system
known
qpcr
use
rapidli
rule
presenc
organ
bodi
fluid
consid
high
neg
predict
valu
short
time
result
techniqu
base
ribosom
deoxyribonucl
acid
dna
amplif
qpcr
util
small
sampl
volum
use
bodili
fluid
pleural
periton
fluid
disadvantag
includ
inabl
perform
antibiot
suscept
test
difficulti
differenti
recent
infect
activ
infect
presenc
contamin
give
fals
posit
result
henc
clinic
correl
made
interpret
result
manag
vari
depend
number
factor
includ
age
site
infect
suspect
caus
organ
microbi
resist
pattern
avail
resourc
consensu
among
author
exist
antibiot
therapi
initi
soon
neonat
sepsi
suspect
consensu
regard
durat
treatment
recommend
canadian
pediatr
societi
cp
aap
recommend
initi
antibiot
therapi
clinic
symptom
present
aap
also
recommend
antibiot
presenc
abnorm
laboratori
valu
one
risk
factor
tabl
presenc
matern
chorioamnion
neonat
clinic
sign
warrant
antibiot
initi
per
aap
present
laboratori
abnorm
per
cp
us
center
diseas
control
prevent
cdc
recommend
empir
antibiot
therapi
newborn
matern
diagnosi
chorioamnion
regardless
infant
clinic
condit
reevalu
hour
discontinu
antibiot
infect
unlik
univers
recommend
antibiot
therapi
includ
intraven
ampicillin
gb
coverag
escherichia
coli
gramneg
bacteria
implic
neonat
sepsi
gentamicin
local
antibiot
resist
pattern
consid
routin
empir
use
broadspectrum
antibiot
agent
consid
among
term
newborn
infant
critic
ill
cultur
result
avail
elect
genet
test
prior
aminoglycosid
use
increasingli
consid
decreas
incid
perman
hear
loss
studi
requir
evalu
neonat
set
lowresourc
set
hospit
possibl
use
intramuscular
gentamicin
oral
amoxicillin
lieu
intraven
medic
recommend
earli
diagnosi
appropri
antibiot
administr
time
support
manag
key
success
treatment
case
attribut
staphylococcu
speci
gb
onethird
caus
gramneg
organ
empir
antibiot
regimen
includ
ampicillin
thirdgener
cephalosporin
meropenem
plu
aminoglycosid
vancomycin
preterm
infant
common
isol
con
vancomycin
teicoplanin
antibiot
choic
proven
signific
con
infect
excess
use
associ
develop
vancomycinresist
enterococcu
vre
infect
gramneg
infect
use
firstlin
antibiot
nosocomi
infect
avoid
combin
flucloxacillin
gentamicin
use
treat
major
case
caus
organ
clindamycin
metronidazol
sometim
ad
cover
anaerob
organ
case
necrot
enterocol
cefotaxim
commonli
reserv
treatment
infant
mening
infant
risk
factor
candid
sepsi
receiv
fungal
empir
therapi
treatment
betalactam
betalactamas
inhibitor
combin
aminoglycosid
enterobact
serratia
pseudomona
sepsi
recommend
mani
expert
meropenem
recommend
preterm
infant
system
extendedspectrum
betalactamas
infect
one
studi
prolong
intraven
infus
meropenem
hour
everi
hour
neonat
gramneg
lon
associ
better
clinic
outcom
compar
convent
strategi
min
everi
h
blood
cultureproven
sepsi
reason
treat
day
shorter
durat
day
treatment
may
consid
select
situat
provid
appropri
followup
ensur
serial
daili
blood
cultur
perform
blood
cultur
neg
serial
crp
measur
may
also
use
decid
discontinu
antibiot
infant
symptom
falseneg
blood
cultur
antibiot
given
prenat
mother
blood
sampl
collect
improperli
henc
antibiot
continu
symptomat
infant
posit
blood
cultur
continu
empir
antibiot
therapi
respons
laboratori
test
abnorm
alon
rare
justifi
particularli
among
wellappear
term
infant
prolong
durat
initi
empir
antibiot
treatment
associ
death
necrot
enterocol
among
prematur
infant
resourcepoor
countri
empir
antibiot
therapi
individu
hospit
region
consult
pediatr
infecti
diseas
specialist
warrant
failur
steril
bloodstream
ie
resist
atyp
organ
sitespecif
infect
use
pentoxifyllin
neonat
sepsi
demonstr
significantli
decreas
allcaus
mortal
hospit
stay
underdevelop
develop
countri
warrant
investig
larg
random
clinic
trial
capabl
countri
hydrocortison
cytokinesuppress
effect
may
improv
patient
cardiovascular
statu
wbcdiff
crp
h
evalu
prospect
random
clinic
trial
treatment
neonat
septic
shock
immunotherapeut
intervent
intraven
immunoglobulin
ivig
infus
igmenrich
intraven
immunoglobulin
granulocytemacrophag
colonystimul
factor
recommend
intens
care
mainten
cerebr
perfus
oxygen
prevent
hypoglycemia
crucial
aspect
manag
combin
ampicillin
cefotaxim
aminoglycosid
suggest
differ
author
cefotaxim
plu
aminoglycosid
good
choic
initi
treatment
gramneg
mening
due
adequ
central
nervou
system
cn
penetr
ceftriaxon
may
increas
risk
kernicteru
first
week
life
avoid
age
rang
uncompl
mening
durat
treatment
day
gb
listeria
monocytogen
streptococcu
pneumonia
day
pseudomona
aeruginosa
gramneg
enter
bacteria
escherichia
coli
longer
durat
therapi
recommend
complic
case
delay
clinic
improv
consult
pediatr
infecti
diseas
specialist
warrant
case
complic
mening
neuroimag
option
includ
cranial
sonographi
magnet
reson
imag
may
provid
prognost
inform
empir
treatment
intraven
acyclovir
mgkgdose
everi
h
recommend
case
asept
mening
suspect
meningoenceph
dosag
adjust
warrant
patient
less
week
gestat
age
patient
signific
hepat
renal
failur
treatment
continu
day
local
infect
day
dissemin
diseas
cn
infect
case
neonat
hsv
suppress
therapi
acyclovir
mgm
per
dose
oral
time
per
day
month
immedi
follow
parenter
treatment
may
improv
outcom
cn
diseas
reduc
recurr
prompt
diagnosi
recognit
risk
factor
earli
administr
antibiot
support
treatment
import
success
treat
congenit
pneumonia
commonli
use
antibiot
includ
ampicillin
gentamicin
cephalosporin
may
consid
failur
therapi
aforement
drug
streptococcu
pneumonia
suspect
support
therapi
includ
surfact
replac
nitric
oxid
inhal
persist
pulmonari
hypertens
newborn
proven
prevent
strategi
eon
appropri
administr
matern
iap
measur
postul
decreas
neonat
infect
intens
care
unit
includ
consumpt
mlkgday
fresh
nondonor
human
milk
probiot
well
restrict
fluconazol
lactoferrin
neither
gb
iap
aforement
prevent
measur
prevent
bacteri
lon
guidelin
prevent
perinat
transmiss
hsv
recommend
cesarean
deliveri
women
activ
genit
lesion
prodrom
symptom
also
recommend
pregnant
women
histori
genit
herp
infect
begin
take
oral
suppress
therapi
week
gestat
though
rate
neonat
sepsi
declin
part
world
global
continu
signific
problem
test
modal
identif
diagnosi
neonat
sepsi
continu
develop
new
laboratori
techniqu
still
test
monitor
manag
risk
factor
well
iap
remain
highli
import
prevent
control
infect
vulner
popul
treatment
includ
prompt
antibiot
administr
support
care
appropri
hospit
set
continu
vigil
key
diagnosi
manag
neonat
sepsi
conflict
interest
author
declar
conflict
interest
human
anim
right
inform
consent
articl
contain
studi
human
anim
subject
perform
author
